vs
Side-by-side financial comparison of Cytosorbents Corp (CTSO) and Marygold Companies, Inc. (MGLD). Click either name above to swap in a different company.
Cytosorbents Corp is the larger business by last-quarter revenue ($9.2M vs $7.6M, roughly 1.2× Marygold Companies, Inc.). Marygold Companies, Inc. runs the higher net margin — -7.5% vs -59.5%, a 52.0% gap on every dollar of revenue. On growth, Cytosorbents Corp posted the faster year-over-year revenue change (0.9% vs -4.5%). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs -1.5%).
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.
CTSO vs MGLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $7.6M |
| Net Profit | $-5.5M | $-576.0K |
| Gross Margin | 73.7% | 74.0% |
| Operating Margin | -47.5% | -8.3% |
| Net Margin | -59.5% | -7.5% |
| Revenue YoY | 0.9% | -4.5% |
| Net Profit YoY | 27.4% | 67.0% |
| EPS (diluted) | $-0.09 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $7.6M | ||
| Q3 25 | $9.5M | $7.0M | ||
| Q2 25 | $9.6M | $7.2M | ||
| Q1 25 | $8.7M | $7.0M | ||
| Q4 24 | $9.2M | $8.0M | ||
| Q3 24 | $8.6M | $7.9M | ||
| Q2 24 | $8.8M | $8.3M | ||
| Q1 24 | $9.0M | $7.9M |
| Q4 25 | $-5.5M | $-576.0K | ||
| Q3 25 | $-3.2M | $-356.0K | ||
| Q2 25 | $1.9M | $-1.5M | ||
| Q1 25 | $-1.5M | $-1.0M | ||
| Q4 24 | $-7.6M | $-1.7M | ||
| Q3 24 | $-2.8M | $-1.6M | ||
| Q2 24 | $-4.3M | $-1.9M | ||
| Q1 24 | $-6.1M | $-529.0K |
| Q4 25 | 73.7% | 74.0% | ||
| Q3 25 | 70.3% | 77.0% | ||
| Q2 25 | 70.9% | 67.8% | ||
| Q1 25 | 71.1% | 75.0% | ||
| Q4 24 | 68.4% | 74.1% | ||
| Q3 24 | 61.0% | 73.1% | ||
| Q2 24 | 73.5% | 72.5% | ||
| Q1 24 | 76.5% | 70.5% |
| Q4 25 | -47.5% | -8.3% | ||
| Q3 25 | -30.2% | -18.2% | ||
| Q2 25 | -37.6% | -16.5% | ||
| Q1 25 | -44.5% | -21.4% | ||
| Q4 24 | -37.1% | -22.8% | ||
| Q3 24 | -56.1% | -27.4% | ||
| Q2 24 | -40.4% | -33.3% | ||
| Q1 24 | -51.8% | -18.7% |
| Q4 25 | -59.5% | -7.5% | ||
| Q3 25 | -33.4% | -5.1% | ||
| Q2 25 | 20.2% | -20.4% | ||
| Q1 25 | -16.9% | -14.4% | ||
| Q4 24 | -82.7% | -21.8% | ||
| Q3 24 | -32.1% | -20.1% | ||
| Q2 24 | -48.6% | -22.5% | ||
| Q1 24 | -67.7% | -6.7% |
| Q4 25 | $-0.09 | $-0.01 | ||
| Q3 25 | $-0.05 | $-0.01 | ||
| Q2 25 | $0.03 | $-0.04 | ||
| Q1 25 | $-0.02 | $-0.02 | ||
| Q4 24 | $-0.14 | $-0.04 | ||
| Q3 24 | $-0.05 | $-0.04 | ||
| Q2 24 | $-0.08 | $-0.05 | ||
| Q1 24 | $-0.11 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.2M | $11.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.9M | $22.7M |
| Total Assets | $44.2M | $27.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.2M | $11.6M | ||
| Q3 25 | $7.5M | $12.5M | ||
| Q2 25 | $10.2M | $12.8M | ||
| Q1 25 | $11.6M | $15.6M | ||
| Q4 24 | $3.3M | $14.9M | ||
| Q3 24 | $5.7M | $17.5M | ||
| Q2 24 | $8.5M | $15.0M | ||
| Q1 24 | $8.6M | $16.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.8M | — | ||
| Q2 24 | $13.7M | — | ||
| Q1 24 | $4.4M | — |
| Q4 25 | $5.9M | $22.7M | ||
| Q3 25 | $9.0M | $22.9M | ||
| Q2 25 | $11.6M | $23.0M | ||
| Q1 25 | $14.5M | $24.3M | ||
| Q4 24 | $11.1M | $23.4M | ||
| Q3 24 | $13.4M | $25.5M | ||
| Q2 24 | $17.4M | $26.6M | ||
| Q1 24 | $19.6M | $28.4M |
| Q4 25 | $44.2M | $27.8M | ||
| Q3 25 | $45.8M | $28.4M | ||
| Q2 25 | $48.0M | $30.4M | ||
| Q1 25 | $50.8M | $33.5M | ||
| Q4 24 | $47.4M | $33.0M | ||
| Q3 24 | $47.8M | $35.9M | ||
| Q2 24 | $53.4M | $32.9M | ||
| Q1 24 | $47.1M | $33.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.23× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.8M | $-908.0K |
| Free Cash FlowOCF − Capex | $-4.9M | — |
| FCF MarginFCF / Revenue | -53.4% | — |
| Capex IntensityCapex / Revenue | 1.2% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.8M | $-908.0K | ||
| Q3 25 | $-2.6M | $-533.0K | ||
| Q2 25 | $-1.5M | $-3.3M | ||
| Q1 25 | $-3.5M | $-1.2M | ||
| Q4 24 | $-2.3M | $-770.0K | ||
| Q3 24 | $-2.5M | $-893.0K | ||
| Q2 24 | $-4.8M | $-1.9M | ||
| Q1 24 | $-4.8M | $-658.0K |
| Q4 25 | $-4.9M | — | ||
| Q3 25 | $-2.6M | $-562.0K | ||
| Q2 25 | $-1.5M | $-3.4M | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $-2.4M | $-776.0K | ||
| Q3 24 | $-2.6M | $-940.0K | ||
| Q2 24 | $-4.8M | $-2.0M | ||
| Q1 24 | $-4.9M | — |
| Q4 25 | -53.4% | — | ||
| Q3 25 | -27.3% | -8.1% | ||
| Q2 25 | -16.1% | -46.8% | ||
| Q1 25 | -39.7% | — | ||
| Q4 24 | -26.3% | -9.7% | ||
| Q3 24 | -30.4% | -11.9% | ||
| Q2 24 | -54.4% | -23.8% | ||
| Q1 24 | -54.2% | — |
| Q4 25 | 1.2% | 0.0% | ||
| Q3 25 | 0.2% | 0.4% | ||
| Q2 25 | 0.4% | 0.7% | ||
| Q1 25 | 0.0% | 0.0% | ||
| Q4 24 | 0.8% | 0.1% | ||
| Q3 24 | 1.8% | 0.6% | ||
| Q2 24 | 0.2% | 0.7% | ||
| Q1 24 | 0.5% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.78× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
MGLD
| Fund Management Related Party | $4.6M | 60% |
| Food Products | $1.7M | 22% |
| Beauty Products | $1.2M | 15% |
| Other | $268.0K | 4% |
